Selected research
Market Structure
Global Ophthalmic Viscosurgical Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Ophthalmic Viscosurgical Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Ophthalmic Viscosurgical Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Ophthalmic Viscosurgical Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Ophthalmic Viscosurgical Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Ophthalmic Viscosurgical Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Ophthalmic Viscosurgical Devices include Abbott Medical Optics, Allergan, Carl-Zeiss, CIMA Technology, Hyaltech, Rayner, Valeant Pharma, Eyebright Medical and Imeik Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Ophthalmic Viscosurgical Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Ophthalmic Viscosurgical Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ophthalmic Viscosurgical Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ophthalmic Viscosurgical Devices market size, projected growth trends, production technologies, key applications, and end-use industries.
Ophthalmic Viscosurgical Devices Segment by Company
Abbott Medical Optics
Allergan
Carl-Zeiss
CIMA Technology
Hyaltech
Rayner
Valeant Pharma
Eyebright Medical
Imeik Technology
Bausch & Lomb Inc.
Haohai Biological
Bloomage Biotechnology
Pfizer
Roche
Novartis
Johnson & Johnson
Ophthalmic Viscosurgical Devices Segment by Type
Combined
Dispersive
Cohesive
Ophthalmic Viscosurgical Devices Segment by Application
Hospitals
Clinics
Others
Ophthalmic Viscosurgical Devices Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Viscosurgical Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Viscosurgical Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Viscosurgical Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Ophthalmic Viscosurgical Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ophthalmic Viscosurgical Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ophthalmic Viscosurgical Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Ophthalmic Viscosurgical Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Combined
- Dispersive
- Cohesive
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Abbott Medical Optics
- Allergan
- Carl-Zeiss
- CIMA Technology
- Hyaltech
- Rayner
- Valeant Pharma
- Eyebright Medical
- Imeik Technology
- Bausch & Lomb Inc.
- Haohai Biological
- Bloomage Biotechnology
- Pfizer
- Roche
- Novartis
- Johnson & Johnson
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Ophthalmic Viscosurgical Devices Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Ophthalmic Viscosurgical Devices Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Ophthalmic Viscosurgical Devices Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Ophthalmic Viscosurgical Devices Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Ophthalmic Viscosurgical Devices Market Dynamics
- 2.1 Ophthalmic Viscosurgical Devices Industry Trends
- 2.2 Ophthalmic Viscosurgical Devices Industry Drivers
- 2.3 Ophthalmic Viscosurgical Devices Industry Opportunities and Challenges
- 2.4 Ophthalmic Viscosurgical Devices Industry Restraints
3 Ophthalmic Viscosurgical Devices Market by Manufacturers
- 3.1 Global Ophthalmic Viscosurgical Devices Revenue by Manufacturers (2021-2026)
- 3.2 Global Ophthalmic Viscosurgical Devices Sales by Manufacturers (2021-2026)
- 3.3 Global Ophthalmic Viscosurgical Devices Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Ophthalmic Viscosurgical Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ophthalmic Viscosurgical Devices Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Ophthalmic Viscosurgical Devices Manufacturers, Product Type & Application
- 3.7 Global Ophthalmic Viscosurgical Devices Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ophthalmic Viscosurgical Devices Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ophthalmic Viscosurgical Devices Players Market Share by Revenue in 2025
- 3.8.3 2025 Ophthalmic Viscosurgical Devices Tier 1, Tier 2, and Tier 3
4 Ophthalmic Viscosurgical Devices Market by Type
- 4.1 Ophthalmic Viscosurgical Devices Type Introduction
- 4.1.1 Combined
- 4.1.2 Dispersive
- 4.1.3 Cohesive
- 4.2 Global Ophthalmic Viscosurgical Devices Sales by Type
- 4.2.1 Global Ophthalmic Viscosurgical Devices Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ophthalmic Viscosurgical Devices Sales by Type (2021-2032)
- 4.2.3 Global Ophthalmic Viscosurgical Devices Sales Market Share by Type (2021-2032)
- 4.3 Global Ophthalmic Viscosurgical Devices Revenue by Type
- 4.3.1 Global Ophthalmic Viscosurgical Devices Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Ophthalmic Viscosurgical Devices Revenue by Type (2021-2032)
- 4.3.3 Global Ophthalmic Viscosurgical Devices Revenue Market Share by Type (2021-2032)
5 Ophthalmic Viscosurgical Devices Market by Application
- 5.1 Ophthalmic Viscosurgical Devices Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Others
- 5.2 Global Ophthalmic Viscosurgical Devices Sales by Application
- 5.2.1 Global Ophthalmic Viscosurgical Devices Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ophthalmic Viscosurgical Devices Sales by Application (2021-2032)
- 5.2.3 Global Ophthalmic Viscosurgical Devices Sales Market Share by Application (2021-2032)
- 5.3 Global Ophthalmic Viscosurgical Devices Revenue by Application
- 5.3.1 Global Ophthalmic Viscosurgical Devices Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Ophthalmic Viscosurgical Devices Revenue by Application (2021-2032)
- 5.3.3 Global Ophthalmic Viscosurgical Devices Revenue Market Share by Application (2021-2032)
6 Global Ophthalmic Viscosurgical Devices Sales by Region
- 6.1 Global Ophthalmic Viscosurgical Devices Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ophthalmic Viscosurgical Devices Sales by Region (2021-2032)
- 6.2.1 Global Ophthalmic Viscosurgical Devices Sales by Region (2021-2026)
- 6.2.2 Global Ophthalmic Viscosurgical Devices Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Ophthalmic Viscosurgical Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Ophthalmic Viscosurgical Devices Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Ophthalmic Viscosurgical Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Ophthalmic Viscosurgical Devices Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Ophthalmic Viscosurgical Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Ophthalmic Viscosurgical Devices Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Ophthalmic Viscosurgical Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Ophthalmic Viscosurgical Devices Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Ophthalmic Viscosurgical Devices Revenue by Region
- 7.1 Global Ophthalmic Viscosurgical Devices Revenue by Region
- 7.1.1 Global Ophthalmic Viscosurgical Devices Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Ophthalmic Viscosurgical Devices Revenue by Region (2021-2026)
- 7.1.3 Global Ophthalmic Viscosurgical Devices Revenue by Region (2027-2032)
- 7.1.4 Global Ophthalmic Viscosurgical Devices Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Ophthalmic Viscosurgical Devices Revenue (2021-2032)
- 7.2.2 North America Ophthalmic Viscosurgical Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Ophthalmic Viscosurgical Devices Revenue (2021-2032)
- 7.3.2 Europe Ophthalmic Viscosurgical Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Ophthalmic Viscosurgical Devices Revenue (2021-2032)
- 7.4.2 Asia-Pacific Ophthalmic Viscosurgical Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Ophthalmic Viscosurgical Devices Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Ophthalmic Viscosurgical Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Abbott Medical Optics
- 8.1.1 Abbott Medical Optics Company Information
- 8.1.2 Abbott Medical Optics Business Overview
- 8.1.3 Abbott Medical Optics Ophthalmic Viscosurgical Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Abbott Medical Optics Ophthalmic Viscosurgical Devices Product Portfolio
- 8.1.5 Abbott Medical Optics Recent Developments
- 8.2 Allergan
- 8.2.1 Allergan Company Information
- 8.2.2 Allergan Business Overview
- 8.2.3 Allergan Ophthalmic Viscosurgical Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Allergan Ophthalmic Viscosurgical Devices Product Portfolio
- 8.2.5 Allergan Recent Developments
- 8.3 Carl-Zeiss
- 8.3.1 Carl-Zeiss Company Information
- 8.3.2 Carl-Zeiss Business Overview
- 8.3.3 Carl-Zeiss Ophthalmic Viscosurgical Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Carl-Zeiss Ophthalmic Viscosurgical Devices Product Portfolio
- 8.3.5 Carl-Zeiss Recent Developments
- 8.4 CIMA Technology
- 8.4.1 CIMA Technology Company Information
- 8.4.2 CIMA Technology Business Overview
- 8.4.3 CIMA Technology Ophthalmic Viscosurgical Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 CIMA Technology Ophthalmic Viscosurgical Devices Product Portfolio
- 8.4.5 CIMA Technology Recent Developments
- 8.5 Hyaltech
- 8.5.1 Hyaltech Company Information
- 8.5.2 Hyaltech Business Overview
- 8.5.3 Hyaltech Ophthalmic Viscosurgical Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Hyaltech Ophthalmic Viscosurgical Devices Product Portfolio
- 8.5.5 Hyaltech Recent Developments
- 8.6 Rayner
- 8.6.1 Rayner Company Information
- 8.6.2 Rayner Business Overview
- 8.6.3 Rayner Ophthalmic Viscosurgical Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Rayner Ophthalmic Viscosurgical Devices Product Portfolio
- 8.6.5 Rayner Recent Developments
- 8.7 Valeant Pharma
- 8.7.1 Valeant Pharma Company Information
- 8.7.2 Valeant Pharma Business Overview
- 8.7.3 Valeant Pharma Ophthalmic Viscosurgical Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Valeant Pharma Ophthalmic Viscosurgical Devices Product Portfolio
- 8.7.5 Valeant Pharma Recent Developments
- 8.8 Eyebright Medical
- 8.8.1 Eyebright Medical Company Information
- 8.8.2 Eyebright Medical Business Overview
- 8.8.3 Eyebright Medical Ophthalmic Viscosurgical Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Eyebright Medical Ophthalmic Viscosurgical Devices Product Portfolio
- 8.8.5 Eyebright Medical Recent Developments
- 8.9 Imeik Technology
- 8.9.1 Imeik Technology Company Information
- 8.9.2 Imeik Technology Business Overview
- 8.9.3 Imeik Technology Ophthalmic Viscosurgical Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Imeik Technology Ophthalmic Viscosurgical Devices Product Portfolio
- 8.9.5 Imeik Technology Recent Developments
- 8.10 Bausch & Lomb Inc.
- 8.10.1 Bausch & Lomb Inc. Company Information
- 8.10.2 Bausch & Lomb Inc. Business Overview
- 8.10.3 Bausch & Lomb Inc. Ophthalmic Viscosurgical Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Bausch & Lomb Inc. Ophthalmic Viscosurgical Devices Product Portfolio
- 8.10.5 Bausch & Lomb Inc. Recent Developments
- 8.11 Haohai Biological
- 8.11.1 Haohai Biological Company Information
- 8.11.2 Haohai Biological Business Overview
- 8.11.3 Haohai Biological Ophthalmic Viscosurgical Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Haohai Biological Ophthalmic Viscosurgical Devices Product Portfolio
- 8.11.5 Haohai Biological Recent Developments
- 8.12 Bloomage Biotechnology
- 8.12.1 Bloomage Biotechnology Company Information
- 8.12.2 Bloomage Biotechnology Business Overview
- 8.12.3 Bloomage Biotechnology Ophthalmic Viscosurgical Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Bloomage Biotechnology Ophthalmic Viscosurgical Devices Product Portfolio
- 8.12.5 Bloomage Biotechnology Recent Developments
- 8.13 Pfizer
- 8.13.1 Pfizer Company Information
- 8.13.2 Pfizer Business Overview
- 8.13.3 Pfizer Ophthalmic Viscosurgical Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Pfizer Ophthalmic Viscosurgical Devices Product Portfolio
- 8.13.5 Pfizer Recent Developments
- 8.14 Roche
- 8.14.1 Roche Company Information
- 8.14.2 Roche Business Overview
- 8.14.3 Roche Ophthalmic Viscosurgical Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Roche Ophthalmic Viscosurgical Devices Product Portfolio
- 8.14.5 Roche Recent Developments
- 8.15 Novartis
- 8.15.1 Novartis Company Information
- 8.15.2 Novartis Business Overview
- 8.15.3 Novartis Ophthalmic Viscosurgical Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Novartis Ophthalmic Viscosurgical Devices Product Portfolio
- 8.15.5 Novartis Recent Developments
- 8.16 Johnson & Johnson
- 8.16.1 Johnson & Johnson Company Information
- 8.16.2 Johnson & Johnson Business Overview
- 8.16.3 Johnson & Johnson Ophthalmic Viscosurgical Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Johnson & Johnson Ophthalmic Viscosurgical Devices Product Portfolio
- 8.16.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Ophthalmic Viscosurgical Devices Value Chain Analysis
- 9.1.1 Ophthalmic Viscosurgical Devices Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Ophthalmic Viscosurgical Devices Production Mode & Process
- 9.2 Ophthalmic Viscosurgical Devices Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ophthalmic Viscosurgical Devices Distributors
- 9.2.3 Ophthalmic Viscosurgical Devices Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst